258 related articles for article (PubMed ID: 14521410)
1. Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Seidler J; McGovern SL; Doman TN; Shoichet BK
J Med Chem; 2003 Oct; 46(21):4477-86. PubMed ID: 14521410
[TBL] [Abstract][Full Text] [Related]
2. Kinase inhibitors: not just for kinases anymore.
McGovern SL; Shoichet BK
J Med Chem; 2003 Apr; 46(8):1478-83. PubMed ID: 12672248
[TBL] [Abstract][Full Text] [Related]
3. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
McGovern SL; Caselli E; Grigorieff N; Shoichet BK
J Med Chem; 2002 Apr; 45(8):1712-22. PubMed ID: 11931626
[TBL] [Abstract][Full Text] [Related]
4. Colloidal aggregation and the in vitro activity of traditional Chinese medicines.
Duan D; Doak AK; Nedyalkova L; Shoichet BK
ACS Chem Biol; 2015 Apr; 10(4):978-88. PubMed ID: 25606714
[TBL] [Abstract][Full Text] [Related]
5. Screening in a spirit haunted world.
Shoichet BK
Drug Discov Today; 2006 Jul; 11(13-14):607-15. PubMed ID: 16793529
[TBL] [Abstract][Full Text] [Related]
6. A detergent-based assay for the detection of promiscuous inhibitors.
Feng BY; Shoichet BK
Nat Protoc; 2006; 1(2):550-3. PubMed ID: 17191086
[TBL] [Abstract][Full Text] [Related]
7. Comparative Molecular Dynamics Simulation of Aggregating and Non-Aggregating Inhibitor Solutions: Understanding the Molecular Basis of Promiscuity.
Ghattas MA; Bryce RA; Al Rawashdah S; Atatreh N; Zalloum WA
ChemMedChem; 2018 Mar; 13(6):500-506. PubMed ID: 29058775
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.
Coan KE; Shoichet BK
J Am Chem Soc; 2008 Jul; 130(29):9606-12. PubMed ID: 18588298
[TBL] [Abstract][Full Text] [Related]
9. High-throughput assays for promiscuous inhibitors.
Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
[TBL] [Abstract][Full Text] [Related]
10. Be Aware of Aggregators in the Search for Potential Human
Viviani LG; Piccirillo E; Cheffer A; de Rezende L; Ulrich H; Carmona-Ribeiro AM; Amaral AT
Molecules; 2018 Jul; 23(8):. PubMed ID: 30060466
[TBL] [Abstract][Full Text] [Related]
11. A specific mechanism of nonspecific inhibition.
McGovern SL; Helfand BT; Feng B; Shoichet BK
J Med Chem; 2003 Sep; 46(20):4265-72. PubMed ID: 13678405
[TBL] [Abstract][Full Text] [Related]
12. Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole.
Niemegeers CJ; Levron JC; Awouters F; Janssen PA
Arch Int Pharmacodyn Ther; 1981 May; 251(1):26-38. PubMed ID: 6266358
[TBL] [Abstract][Full Text] [Related]
13. Colloid formation by drugs in simulated intestinal fluid.
Doak AK; Wille H; Prusiner SB; Shoichet BK
J Med Chem; 2010 May; 53(10):4259-65. PubMed ID: 20426472
[TBL] [Abstract][Full Text] [Related]
14. A high-throughput screen for aggregation-based inhibition in a large compound library.
Feng BY; Simeonov A; Jadhav A; Babaoglu K; Inglese J; Shoichet BK; Austin CP
J Med Chem; 2007 May; 50(10):2385-90. PubMed ID: 17447748
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase.
Babaoglu K; Simeonov A; Irwin JJ; Nelson ME; Feng B; Thomas CJ; Cancian L; Costi MP; Maltby DA; Jadhav A; Inglese J; Austin CP; Shoichet BK
J Med Chem; 2008 Apr; 51(8):2502-11. PubMed ID: 18333608
[TBL] [Abstract][Full Text] [Related]
16. Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors.
Giannetti AM; Koch BD; Browner MF
J Med Chem; 2008 Feb; 51(3):574-80. PubMed ID: 18181566
[TBL] [Abstract][Full Text] [Related]
17. [Effect of imidazole antifungal agents on colony formation by murine bone marrow CFUc (colony forming units in culture].
Benkó I; Megyeri A; Hernádi F; Kovács P
Acta Pharm Hung; 1996 Nov; 66(6):241-5. PubMed ID: 9604489
[TBL] [Abstract][Full Text] [Related]
18. Promiscuous aggregate-based inhibitors promote enzyme unfolding.
Coan KE; Maltby DA; Burlingame AL; Shoichet BK
J Med Chem; 2009 Apr; 52(7):2067-75. PubMed ID: 19281222
[TBL] [Abstract][Full Text] [Related]
19. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
20. Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues.
Carneiro VM; Trivella DB; Scorsato V; Beraldo VL; Dias MP; Sobreira TJ; Aparicio R; Pilli RA
Eur J Med Chem; 2015 Jun; 97():42-54. PubMed ID: 25938987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
